Literature DB >> 2433688

Loss of (2'-5')oligoadenylate synthetase activity by production of antisense RNA results in lack of protection by interferon from viral infections.

A De Benedetti, B A Pytel, C Baglioni.   

Abstract

An expression vector was constructed that carries part of the human BK papovavirus with 0.5 kilobases of (2'-5')oligoadenylate (2-5A) synthetase cDNA inserted in inverted orientation downstream from the virion proteins (VP) promoter and the neomycin-resistance gene neo under the control of a simian virus 40 promoter. Cells transfected with this vector and selected for resistance to the neomycin derivative G418 synthesized RNA complementary to 2-5A synthetase mRNA. These cells lacked 2-5A synthetase activity, and the enzyme was not inducible by interferon. In contrast, 2-5A synthetase was induced in cells transfected with a control vector without the cDNA insert. Such cells were protected by interferon from RNA viruses, whereas cells lacking 2-5A synthetase were not protected from encephalomyocarditis virus, vesicular stomatitis virus, and Sindbis virus but were fully protected from influenza virus. These findings show that a high level of 2-5A synthetase is required for interferon-induced protection from the cytoplasmic RNA viruses tested.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2433688      PMCID: PMC304274          DOI: 10.1073/pnas.84.3.658

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  40 in total

1.  Binding of viral and cellular messenger RNAs to ribosomes in eukaryotic cell extracts.

Authors:  L A Weber; M Simili; C Baglioni
Journal:  Methods Enzymol       Date:  1979       Impact factor: 1.600

2.  Non-producer human cells induced by murine sarcoma virus.

Authors:  J S Rhim; H Y Cho; R J Huebner
Journal:  Int J Cancer       Date:  1975-01-15       Impact factor: 7.396

3.  Aquanititave semimicro, semiautomated colorimetric assay for interferon.

Authors:  E C Borden; P H Leonhardt
Journal:  J Lab Clin Med       Date:  1977-05

4.  Interferon-induced enzymatic activities and their role in the antriviral state.

Authors:  C Baglioni
Journal:  Cell       Date:  1979-06       Impact factor: 41.582

5.  Synthesis of 2'5'-oligo(A) in extracts of interferon-treated HeLa cells.

Authors:  M A Minks; S Benvin; P A Maroney; C Baglioni
Journal:  J Biol Chem       Date:  1979-06-25       Impact factor: 5.157

6.  Selective extraction of polyoma DNA from infected mouse cell cultures.

Authors:  B Hirt
Journal:  J Mol Biol       Date:  1967-06-14       Impact factor: 5.469

7.  Induction of interferon in HeLa cells of a protein kinase activated by double-stranded RNA.

Authors:  D K West; C Baglioni
Journal:  Eur J Biochem       Date:  1979-11

8.  Anti-mitogenic function of interferon-induced (2'-5')oligo(adenylate) and growth-related variations in enzymes that synthesize and degrade this oligonucleotide.

Authors:  A Kimchi; H Shure; M Revel
Journal:  Eur J Biochem       Date:  1981

9.  Virus-specific effects of interferon in embryonal carcinoma cells.

Authors:  T W Nilsen; D L Wood; C Baglioni
Journal:  Nature       Date:  1980-07-10       Impact factor: 49.962

10.  Interferon enhances 2-5A synthetase in embryonal carcinoma cells.

Authors:  J N Wood; A G Hovanessian
Journal:  Nature       Date:  1979-11-01       Impact factor: 49.962

View more
  10 in total

1.  A stable bifunctional antisense transcript inhibiting gene expression in transgenic plants.

Authors:  A J Delauney; Z Tabaeizadeh; D P Verma
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

Review 2.  Cell cross-contamination in cell cultures: the silent and neglected danger.

Authors:  O Markovic; N Markovic
Journal:  In Vitro Cell Dev Biol Anim       Date:  1998-01       Impact factor: 2.416

3.  Posttranscriptional regulation of c-myc proto-oncogene expression and growth inhibition by recombinant human interferon-beta ser17 in a human colon carcinoma cell line.

Authors:  D Chatterjee; T M Savarese
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

4.  In situ detection of a heat-shock regulatory element binding protein using a soluble synthetic enhancer sequence.

Authors:  A Harel-Bellan; A T Brini; D K Ferris; P Robin; W L Farrar
Journal:  Nucleic Acids Res       Date:  1989-06-12       Impact factor: 16.971

5.  Loss of (2'-5')oligoadenylate synthetase activity by production of antisense RNA results in lack of protection by interferon from viral infections.

Authors: 
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

6.  Comparative inhibition of chloramphenicol acetyltransferase gene expression by antisense oligonucleotide analogues having alkyl phosphotriester, methylphosphonate and phosphorothioate linkages.

Authors:  C J Marcus-Sekura; A M Woerner; K Shinozuka; G Zon; G V Quinnan
Journal:  Nucleic Acids Res       Date:  1987-07-24       Impact factor: 16.971

7.  Interferon-responsive regulatory elements in the promoter of the human 2',5'-oligo(A) synthetase gene.

Authors:  P Benech; M Vigneron; D Peretz; M Revel; J Chebath
Journal:  Mol Cell Biol       Date:  1987-12       Impact factor: 4.272

8.  Antisense oligonucleotide-directed cleavage of mRNA in Xenopus oocytes and eggs.

Authors:  J Shuttleworth; A Colman
Journal:  EMBO J       Date:  1988-02       Impact factor: 11.598

9.  Specific inhibition of lymphokine biosynthesis and autocrine growth using antisense oligonucleotides in Th1 and Th2 helper T cell clones.

Authors:  A Harel-Bellan; S Durum; K Muegge; A K Abbas; W L Farrar
Journal:  J Exp Med       Date:  1988-12-01       Impact factor: 14.307

Review 10.  The 2-5A system: modulation of viral and cellular processes through acceleration of RNA degradation.

Authors:  M R Player; P F Torrence
Journal:  Pharmacol Ther       Date:  1998-05       Impact factor: 12.310

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.